Orotic Acid

Orotic Acid

SCHEMBL5651941

O=C(O)c1cc(=O)[nH]c(=O)[nH]1.[Cr]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.95
LMNA P02545 1/20 0.95
CYP2C19 P33261 2/20 0.61
CYP1A2 P05177 2/20 0.57
ALOX15 P16050 1/20 0.54
NFKB1 P19838 1/20 0.54
BLM P54132 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
TSHR P16473 2/20 0.47
GPR84 Q9NQS5 4/20 0.45
GPR35 Q9HC97 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orotic Acid SCHEMBL29394966 0.98 ALDH1A1 (1.00) ALDH1A1LMNACYP2C19CYP1A2ALOX15
Orotic Acid SCHEMBL431534 0.98 ALDH1A1 (1.00) ALDH1A1LMNACYP2C19CYP1A2ALOX15
Orotic Acid SCHEMBL20865 0.98 ALDH1A1 (1.00) ALDH1A1LMNACYP2C19CYP1A2ALOX15
Orotic Acid SCHEMBL122311 0.95 ALDH1A1 (0.95) ALDH1A1LMNACYP2C19CYP1A2ALOX15
Orotic Acid SCHEMBL231368 0.95 ALDH1A1 (0.95) ALDH1A1LMNACYP2C19CYP1A2ALOX15
Orotic Acid SCHEMBL23859825 0.95 ALDH1A1 (0.95) ALDH1A1LMNACYP2C19CYP1A2ALOX15
Orotic Acid SCHEMBL896844 0.95 ALDH1A1 (0.95) ALDH1A1LMNACYP2C19CYP1A2ALOX15
Orotic Acid SCHEMBL1005001 0.95 ALDH1A1 (0.95) ALDH1A1LMNACYP2C19CYP1A2ALOX15
Orotic Acid SCHEMBL7328854 0.95 ALDH1A1 (0.95) ALDH1A1LMNACYP2C19CYP1A2ALOX15
Orotic Acid SCHEMBL16194628 0.95 ALDH1A1 (0.95) ALDH1A1LMNACYP2C19CYP1A2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3212191-B1 TREATMENT FOR DEPRESSION AND DEPRESSIVE DISORDERS MEDLAB IP PTY LTD (AU) 2022-10-05 EP claimed
US-11135181-B2 Treatment for depression and depressive disorders MEDLAB IP PTY LTD (AU) 2021-10-05 US claimed
US-20170312232-A1 TREATMENT FOR DEPRESSION AND DEPRESSIVE DISORDERS MEDLAB IP PTY LTD (AU) 2017-11-02 US claimed
EP-3212191-A1 TREATMENT FOR DEPRESSION AND DEPRESSIVE DISORDERS Medlab IP Pty Ltd. (AU) 2017-09-06 EP claimed
WO-2016065419-A1 TREATMENT FOR DEPRESSION AND DEPRESSIVE DISORDERS MEDLAB IP PTY LTD (AU) 2016-05-06 WO claimed
US-20150335688-A1 PROBIOTIC COMBINATIONS AND USES THEREOF MEDLAB IP PTY LTD (AU) 2015-11-26 US claimed
EP-3212191-B1 TREATMENT FOR DEPRESSION AND DEPRESSIVE DISORDERS MEDLAB IP PTY LTD (AU) 2022-10-05 EP disclosed
US-11135181-B2 Treatment for depression and depressive disorders MEDLAB IP PTY LTD (AU) 2021-10-05 US disclosed
US-20170312232-A1 TREATMENT FOR DEPRESSION AND DEPRESSIVE DISORDERS MEDLAB IP PTY LTD (AU) 2017-11-02 US disclosed
EP-3212191-A1 TREATMENT FOR DEPRESSION AND DEPRESSIVE DISORDERS Medlab IP Pty Ltd. (AU) 2017-09-06 EP disclosed
WO-2016065419-A1 TREATMENT FOR DEPRESSION AND DEPRESSIVE DISORDERS MEDLAB IP PTY LTD (AU) 2016-05-06 WO disclosed
US-20150335688-A1 PROBIOTIC COMBINATIONS AND USES THEREOF MEDLAB IP PTY LTD (AU) 2015-11-26 US disclosed
US-20070227399-A1 COMPOSITIONS AND METHODS FOR THE PRESERVATION OF WOOD NOVUS INTERNATIONAL INC. (US) 2007-10-04 US disclosed
US-6932979-B2 Soluble, gum-containing, coated chewable tablet DR. GERGELY & CO. (AT) 2005-08-23 US disclosed